PET imaging of cellular proliferation.
暂无分享,去创建一个
[1] J. Cleaver. Thymidine metabolism and cell kinetics , 1967 .
[2] D. Mankoff,et al. Kinetic analysis of 2-[carbon-11]thymidine PET imaging studies: compartmental model and mathematical analysis. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[3] Bengt Långström,et al. Rat studies comparing 11C-FMAU, 18F-FLT, and 76Br-BFU as proliferation markers. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[4] I Lemahieu,et al. [Methyl-11C]thymidine positron emission tomography in tumoral and non-tumoral cerebral lesions. , 1999, Acta neurologica Belgica.
[5] R. Blasberg,et al. Iododeoxyuridine uptake and retention as a measure of tumor growth. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[6] T K Lewellen,et al. Carbon-11-thymidine and FDG to measure therapy response. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[7] I. Ellis,et al. Assessment of the new proliferation marker MIB1 in breast carcinoma using image analysis: associations with other prognostic factors and survival. , 1995, British Journal of Cancer.
[8] A. Shields,et al. Development of labeled thymidine analogs for imaging tumor proliferation. , 1996, Nuclear medicine and biology.
[9] A. Wolf,et al. Detection of DNA synthesis in intact organisms with positron-emitting (methyl- 11 C)thymidine. , 1972, Proceedings of the National Academy of Sciences of the United States of America.
[10] D. Visvikis,et al. Comparison of methodologies for the in vivo assessment of 18FLT utilisation in colorectal cancer , 2004, European Journal of Nuclear Medicine and Molecular Imaging.
[11] H. Dittmann,et al. [18F]FLT PET for diagnosis and staging of thoracic tumours , 2003, European Journal of Nuclear Medicine and Molecular Imaging.
[12] O. Muzik,et al. Kinetics of 3'-deoxy-3'-[F-18]fluorothymidine uptake and retention in dogs. , 2002, Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging.
[13] Otto Muzik,et al. Imaging proliferation in vivo with [F-18]FLT and positron emission tomography , 1998, Nature Medicine.
[14] R. Blasberg,et al. Imaging brain tumor proliferative activity with [124I]iododeoxyuridine. , 2000, Cancer research.
[15] H. Hoekstra,et al. 3'-18F-fluoro-3'-deoxy-L-thymidine: a new tracer for staging metastatic melanoma? , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[16] T. Borght,et al. Brain tumor imaging with PET and 2-[carbon-11]thymidine. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[17] G. V. von Schulthess,et al. Non-invasive assessment of tumour cell proliferation with positron emission tomography and [76Br]bromodeoxyuridine. , 1999, Melanoma research.
[18] Mark Muzi,et al. Kinetic modeling of 3'-deoxy-3'-fluorothymidine in somatic tumors: mathematical studies. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[19] W. Vaalburg,et al. 18F-FLT PET for visualization of laryngeal cancer: comparison with 18F-FDG PET. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[20] M. Bergström,et al. In vitro and animal validation of bromine-76-bromodeoxyuridine as a proliferation marker. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[21] L. Wiens,et al. Validation of FLT uptake as a measure of thymidine kinase-1 activity in A549 carcinoma cells. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[22] S. Akiyama,et al. Role of thymidine phosphorylase activity in the angiogenic effect of platelet derived endothelial cell growth factor/thymidine phosphorylase. , 1995, Cancer research.
[23] H. Thierens,et al. [Methyl-carbon-11] thymidine for in vivo measurement of cell proliferation. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[24] Torsten Mattfeldt,et al. 3-deoxy-3-[(18)F]fluorothymidine-positron emission tomography for noninvasive assessment of proliferation in pulmonary nodules. , 2002, Cancer research.
[25] O. Muzik,et al. Imaging [18F]FAU [1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl) uracil] in dogs. , 2003, Nuclear medicine and biology.
[26] Sven N Reske,et al. 3'-[18F]fluoro-3'-deoxythymidine ([18F]-FLT) as positron emission tomography tracer for imaging proliferation in a murine B-Cell lymphoma model and in the human disease. , 2003, Cancer research.
[27] P. Goethals,et al. Measurement of [methyl-carbon-11]thymidine and its metabolites in head and neck tumors. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[28] Finbarr O'Sullivan,et al. Imaging radiotracer model parameters in PET: a mixture analysis approach , 1993, IEEE Trans. Medical Imaging.
[29] K. Krohn,et al. Monitoring tumor cell proliferation by targeting DNA synthetic processes with thymidine and thymidine analogs. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[30] D. Kuebbing,et al. A model for compartmentation of de novo and salvage thymidine nucleotide pools in mammalian cells. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[31] F Daghighian,et al. Imaging of brain tumor proliferative activity with iodine-131-iododeoxyuridine. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[32] G. Slegers,et al. Synthesis of 11C-labelled thymidine for tumor visualization using positron emission tomography. , 1989, International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes.
[33] M. Bergström,et al. Synthesis of [76Br]bromofluorodeoxyuridine and its validation with regard to uptake, DNA incorporation, and excretion modulation in rats. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[34] D. Mankoff,et al. Positron-emission tomographic imaging of cancer: glucose metabolism and beyond. , 2001, Seminars in radiation oncology.
[35] Roger N Gunn,et al. 2-[11C]thymidine positron emission tomography as an indicator of thymidylate synthase inhibition in patients treated with AG337. , 2003, Journal of the National Cancer Institute.
[36] S. Pauwels,et al. Production of [2-11C]thymidine for quantification of cellular proliferation with PET. , 1991, International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes.
[37] D. Mankoff,et al. A graphical analysis method to estimate blood-to-tissue transfer constants for tracers with labeled metabolites. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[38] P. Plagemann,et al. THYMIDINE TRANSPORT BY CULTURED NOVIKOFF HEPATOMA CELLS AND UPTAKE BY SIMPLE DIFFUSION AND RELATIONSHIP TO INCORPORATION INTO DEOXYRIBONUCLEIC ACID , 1972, The Journal of cell biology.
[39] Y. Yonekura,et al. Basis of FLT as a cell proliferation marker: comparative uptake studies with [3H]thymidine and [3H]arabinothymidine, and cell-analysis in 22 asynchronously growing tumor cell lines. , 2002, Nuclear medicine and biology.
[40] Imaging Cellular Proliferation as a Measure of Response to Therapy , 2001, Journal of clinical pharmacology.
[41] D. Visvikis,et al. Potential impact of [18F]3'-deoxy-3'-fluorothymidine versus [18F]fluoro-2-deoxy-d-glucose in positron emission tomography for colorectal cancer , 2003, European Journal of Nuclear Medicine and Molecular Imaging.
[42] D. Mankoff,et al. Kinetic analysis of 2-[11C]thymidine PET imaging studies: validation studies. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[43] W. Oldendorf,et al. Independent blood-brain barrier transport systems for nucleic acid precursors. , 1975, Biochimica et biophysica acta.
[44] R. Zarbo,et al. Clinical application of morphologic and immunocytochemical assessments of cell proliferation. , 1992, American journal of clinical pathology.
[45] R. Livingston,et al. The clinical applications of cell kinetics in cancer therapy. , 1977, Annual review of pharmacology and toxicology.
[46] A general method to correct PET data for tissue metabolites using a dual-scan approach. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[47] I. Lemahieu,et al. Measurement of short-term 11C-thymidine activity in human head and neck tumours using positron emission tomography (PET). , 1992, Acta oncologica.
[48] A. Shields,et al. PET imaging with 18F-FLT and thymidine analogs: promise and pitfalls. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[49] S M Larson,et al. Positron imaging feasibility studies. I: Characteristics of [3H]thymidine uptake in rodent and canine neoplasms: concise communication. , 1981, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[50] P. Conti,et al. Selective alkylation of pyrimidyl-dianions: synthesis and purification of 11C labeled thymidine for tumor visualization using positron emission tomography , 1984 .
[51] H. Thierens,et al. Kinetics of [methyl-11C]thymidine in patients with squamous cell carcinoma of the head and neck. , 1996, Acta oncologica.
[52] J. Ryser,et al. [76Br]Bromodeoxyuridine, a potential tracer for the measurement of cell proliferation by positron emission tomography, in vitro and in vivo studies in mice. , 1999, Nuclear medicine and biology.
[53] C Flexner,et al. Relationship between plasma concentrations of 3'-deoxy-3'-fluorothymidine (alovudine) and antiretroviral activity in two concentration-controlled trials. , 1994, The Journal of infectious diseases.
[54] Mark Muzi,et al. In vivo validation of 3'deoxy-3'-[(18)F]fluorothymidine ([(18)F]FLT) as a proliferation imaging tracer in humans: correlation of [(18)F]FLT uptake by positron emission tomography with Ki-67 immunohistochemistry and flow cytometry in human lung tumors. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[55] D. Mankoff,et al. Analysis of 2-carbon-11-thymidine blood metabolites in PET imaging. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[56] A. Shields,et al. Cellular sources of thymidine nucleotides: studies for PET. , 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[57] R. Livingston,et al. In vitro determination of thymidine-3H labeling index in human solid tumors. , 1974, Cancer research.
[58] D. Mankoff,et al. 18F-Fluorothymidine radiation dosimetry in human PET imaging studies. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[59] A. Shields,et al. Synthesis of 2'-deoxy-2'-[18F]fluoro-beta-D-arabinofuranosyl nucleosides, [18F]FAU, [18F]FMAU, [18F]FBAU and [18F]FIAU, as potential PET agents for imaging cellular proliferation. Synthesis of [18F]labelled FAU, FMAU, FBAU, FIAU. , 2003, Nuclear medicine and biology.
[60] S. Osman,et al. Assessment of proliferation in vivo using 2-[(11)C]thymidine positron emission tomography in advanced intra-abdominal malignancies. , 2002, Cancer research.
[61] A. Shields,et al. Radiosynthesis of 3'-deoxy-3'-[(18)F]fluorothymidine: [(18)F]FLT for imaging of cellular proliferation in vivo. , 2000, Nuclear medicine and biology.
[62] P. Martiat,et al. In vivo measurement of carbon-11 thymidine uptake in non-Hodgkin's lymphoma using positron emission tomography. , 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[63] J. Bading,et al. Pharmacokinetics of the thymidine analog 2'-fluoro-5-[(14)C]-methyl-1-beta-D-arabinofuranosyluracil ([(14)C]FMAU) in rat prostate tumor cells. , 2000, Nuclear medicine and biology.
[64] F. O’Sullivan,et al. Kinetic analysis of 2-[11C]thymidine PET imaging studies of malignant brain tumors: preliminary patient results. , 2002, Molecular imaging.
[65] D. Visvikis,et al. In vivo imaging of cellular proliferation in colorectal cancer using positron emission tomography , 2003, Gut.
[66] J B Bassingthwaighte,et al. Contribution of labeled carbon dioxide to PET imaging of carbon-11-labeled compounds. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[67] C. R. Crawford,et al. Nucleoside transport in normal and neoplastic cells. , 1993, Advances in enzyme regulation.
[68] V. Grégoire,et al. Use of 5-[76Br]bromo-2'-fluoro-2'-deoxyuridine as a ligand for tumour proliferation: validation in an animal tumour model , 2001, European Journal of Nuclear Medicine and Molecular Imaging.
[69] Torsten Mattfeldt,et al. Imaging proliferation in lung tumors with PET: 18F-FLT versus 18F-FDG. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[70] R. Wohlhueter,et al. Thymidine transport in cultured mammalian cells. Kinetic analysis, temperature dependence and specificity of the transport system. , 1979, Biochimica et biophysica acta.
[71] F. O’Sullivan,et al. Kinetic analysis of 2-[11C]thymidine PET imaging studies of malignant brain tumors: compartmental model investigation and mathematical analysis. , 2002, Molecular imaging.
[72] M. Berger,et al. 2-[C-11]thymidine imaging of malignant brain tumors. , 1999, Cancer research.
[73] R. Finn,et al. Radiosynthesis and quality assurance of 5-[124I]Iodo-2'-deoxyuridine for functional PET imaging of cell proliferation. , 1998, Nuclear medicine and biology.
[74] S M Larson,et al. Short-term thymidine uptake in normal and neoplastic tissues: studies for PET. , 1984, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[75] J. Sherley,et al. Regulation of human thymidine kinase during the cell cycle. , 1988, The Journal of biological chemistry.
[76] P. Conti,et al. Synthesis of 2'-fluoro-5-[11C]-methyl-1-beta-D-arabinofuranosyluracil ([11C]-FMAU): a potential nucleoside analog for in vivo study of cellular proliferation with PET. , 1995, Nuclear medicine and biology.
[77] H. Mandel,et al. Mitochondrial deoxyribonucleoside triphosphate pools in thymidine kinase 2 deficiency. , 2003, Biochemical and biophysical research communications.
[78] Richard P. Hill,et al. The Basic Science of Oncology , 1989 .